HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Steven R. Gundry Hironori Izutani Leonard L. Bailey Permission Requests Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Asano, M. Articles by Bailey, L. L. Search for Related Content PubMed PubMed Citation Articles by Asano, M. Articles by Bailey, L. L. Related Collections Transplantation - heart

J Thorac Cardiovasc Surg 2003;125:60-70
© 2003 The American Association for Thoracic Surgery

Surgery for Congenital Heart Disease (CHD)

Baboons undergoing orthotopic concordant cardiac xenotransplantation surviving more than 300 days: Effect of immunosuppressive regimen

From the Department of Surgery^a and Immunology Center,^b Loma Linda University Medical School and Medical Center, Loma Linda, Calif.

Read at the Eightieth Annual Meeting of The American Association for Thoracic Surgery, Toronto, Ontario, Canada, May 1-3, 2000.

Received for publication May 4, 2000. Revisions requested July 31, 2000; revisions received Aug 22, 2002. Accepted for publication Sept 9, 2002. Address for reprints: Steven R. Gundry, MD, Department of Surgery, Loma Linda University Medical School and Medical Center, 11175 Campus St, Suite 21121, Loma Linda, CA 92354 (E-mail: Steven.Gundry{at}tenethealth.com).

Objective: We reviewed long-term survival among hosts in 3 consecutive series of a rhesus monkey-baboon orthotopic cardiac xenotransplantation model with reference to host immune response, including the effectiveness in preventing rejection and limiting toxicity concerning infection, to evaluate specific immunosuppressive regimens for long-term outcomes.
Methods: Six juvenile baboons surviving more than 300 days after transplantation were reviewed. Regimen A consisted of splenectomy, FK506, methotrexate, and antilymphocyte globulin. Regimen B consisted of pretransplantation and chronic maintenance with cyclosporine A (INN: ciclosporin), methotrexate, and antithymocyte globulin. Regimen C was the same as regimen B plus pretransplantation total lymphoid irradiation and intraoperative donor bone marrow cell infusion. Rejections were detected by means of echocardiography.
Results: Long-term survivors in 3 groups were followed for a range of 332 to 515 days (mean, 436 days). Rejection frequency in regimens A, B, and C was 0.35, 0.58, and 0.18 per month, and rescue therapy days were 23 (4.8%), 123 (9.5%), and 20 (2.4%), respectively (P < .0001). Infection frequency was 0.58, 0.56, and 0.19 per month, and therapy days were 192 (38.2%), 164 (12.6%), and 7 (0.9%), respectively (P < .0001). Concerning the host immune response, interleukin 2-activated T cells of all groups during rejection-free periods showed lower numbers compared with those of control animals (P < .0005), and regimen C was the lowest among 3 groups (P < .01). The production of xenoantibody was sufficiently attenuated in all groups.
Conclusion: Regimen C leads to long-term survival with fewer rejection and infection episodes by means of suppression of the interleukin 2 pathway and xenoantibody production.